In a bylined article, Litigation & Dispute Resolution partners Mark Mansour and Christopher Mikson and associate Emily Strunk (all Washington DC) discuss guidance the FDA has issued addressing the higher standard for interchangeability.
To read this complete article visit Law360.
Downloads –
Related Capabilities
Practices –
Latest Perspectives
Stay up-to-date on our perspectives
Subscribe to Email